Inhaled recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) needed to clear lung surfactant improved ...

Columnist Sam Kirton takes readers on his journey from a pulmonary function test to his results from lung biopsies that weren't routine.

A persistent cough may seem harmless, but in rare cases it could signal pulmonary fibrosis, a serious lung-scarring condition ...

Rheumatoid arthritis may play a causal role in idiopathic pulmonary fibrosis but not vice versa, with some shared plasma ...

For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration (FDA) has ...

Researchers have found a promising treatment breakthrough for chronic obstructive pulmonary disease (COPD) that avoids many ...

The study found through multi-omics integration analysis that rheumatoid arthritis is a causal factor of idiopathic pulmonary fibrosis, identifying CCL2 and CXCL2 as shared biomarkers between the ...

VIRGINIA BEACH, Va. (WAVY) —This weekend, there is a race for a good cause in Virginia Beach— the third annual Breathe n Run 5K, with the event supporting pulmonary fibrosis and honoring one ...

After several tests, a pulmonologist gave him an alarming diagnosis: Idiopathic pulmonary fibrosis, or IPF.

IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for reversing scarring.

This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.

Recently these monocyte-derived alveolar macrophages, or Mo-AMs, were identified as key drivers of lung fibrosis disease progression. However, the mechanisms of their pro-fibrotic behavior and ...